A review of co‐morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co‐use
Tóm tắt
Tobacco and cannabis are among the most commonly used psychoactive substances worldwide, and are often used in combination. Evidence suggests that tobacco use contributes to an increased likelihood of becoming cannabis dependent and similarly cannabis use promotes transition to more intensive tobacco use. Further, tobacco use threatens cannabis cessation attempts leading to increased and accelerated relapse rates among cigarette smokers. Given that treatment outcomes are far from satisfactory among individuals engaged in both tobacco and cannabis use highlights the need for further exploration of this highly prevalent co‐morbidity.
Therefore, this review will elucidate putative neurobiological mechanisms responsible for facilitating the link between co‐morbid tobacco and cannabis use.
We performed an extensive literature search identifying published studies that examined co‐morbid tobacco and cannabis use.
Evidence of both synergistic and compensatory effects of co‐morbid tobacco and cannabis use have been identified. Following, co‐morbid use of these substances will be discussed within the context of two popular theories of addiction: the addiction vulnerability hypothesis and the gateway hypothesis. Lastly, common route of administration is proposed as a facilitator for co‐morbid use.
While, only a paucity of treatment studies addressing co‐morbid tobacco and cannabis use have been conducted, emerging evidence suggests that simultaneously quitting both tobacco and cannabis may yield benefits at both the psychological and neurobiological level. More research is needed to confirm this intervention strategy and future studies should consider employing prospective systematic designs. (Am J Addict 2015;24:105–116)
Từ khóa
Tài liệu tham khảo
UNODC.World Drug Report 2012. New York2012.
Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: Detailed tables. Rockville MD: Substance Abuse and Mental Health Services Administration; 2008.
Fiore MC Bailey WC Cohen SJ Dorfman SF Goldstein MG Gritz ER. Treating Tobacco Use and Dependence. Rockville MD 2000.
WHO;. Tobacco Free Initiative. 2012.
Budney AJ, 2008, Health consequences of marijuana use, 171
Golub AL. The Cultural/Subcultural Contexts of Marijuana Use at the Turn of the Twenty‐First Century. Haworth Press; 2006.
Benowitz NL, 1982, Interindividual variability in the metabolism and cardiovascular effects of nicotine in man, J Pharmacol Exp Ther, 221, 368
Compton DR, 1992, Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents, J Pharmacol Exp Ther, 260, 201
Meng Y, 1997, Inhalation studies with drugs of abuse, NIDA Res Monogr, 173, 201
George TP. Nicotine and Tobacco. Vol 24th Edition New York 2011.
Schuster CR, 1975, Drugs as reinforcers in monkey and man, Pharmacol Rev, 27, 551
Penetar DM, 2012, Bupropion reduces some of the symptoms of marihuana withdrawal in chronic marihuana users: A pilot study, Subst Abuse, 6, 63